Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation‐Related Biomarkers: A GRADE‐Assessed Systematic Review and Updated Meta‐Analysis of Randomized Controlled Trials
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202200800 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Shanshan Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong Province, 518107, P. R. China. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Interleukin-6. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
Scope Coenzyme Q10 (CoQ10) has become a popular nutritional supplement due to its wide range of beneficial biological effects. Previous meta‐analyses show that the attenuation of CoQ10 on inflammatory biomarkers remains controversial. This meta‐analysis aims to assess the efficacy and optimal dose of CoQ10 supplementation on inflammatory indicators in the general population. Methods and results Databases are searched up to December 2022 resulting in 6713 articles, of which 31 are retrieved for full‐text assessment and included 1517 subjects. Double‐blind randomized controlled trials (RCTs) of CoQ10 supplementation are eligible if they contain C reactive protein (CRP), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α). CoQ10 supplementation can significantly reduce the levels of circulating CRP (SMD: −0.40, 95% CI: [−0.67 to −0.13], p = 0.003), IL‐6 (SMD: −0.67, 95% CI: [−1.01 to −0.33], p < 0.001), and TNF‐α (SMD: −1.06, 95% CI: [−1.59 to −0.52], p < 0.001) and increase the concentration of circulating CoQ10. Conclusion This meta‐analysis provides evidence for CoQ10 supplementation to reduce the level of inflammatory mediators in the general population and proposes that daily supplementation of 300–400 mg CoQ10 show superior inhibition of inflammatory factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong Province, 518107, P. R. China.
- Guangdong Provincial Key Laboratory of Food, Nutrition, and Health, Sun Yat-sen University, Guangzhou, Guangdong Province, 510000, P. R. China.
- Guangdong Engineering Technology Center of Nutrition Transformation, Sun Yat-sen University, Guangzhou, Guangdong Province, 510000, P. R. China.
- School of Public Health, Baotou Medical College, Baotou, Inner Mongolia, 014040, P. R. China.
- China-DRIs Expert Committee, Beijing, P. R. China.
ORCID-Profile: Yan Yang
Zitieren
APA
Hou, S., Tian, Z., Zhao, D., Liang, Y., Dai, S., Ji, Q., Fan, Z., Liu, Z., Liu, M., & Yang, Y. (2023). Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation‐Related Biomarkers: A GRADE‐Assessed Systematic Review and Updated Meta‐Analysis of Randomized Controlled Trials. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202200800
Vancouver
Hou S, Tian Z, Zhao D, Liang Y, Dai S, Ji Q, et al. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation‐Related Biomarkers: A GRADE‐Assessed Systematic Review and Updated Meta‐Analysis of Randomized Controlled Trials. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202200800
BibTeX
@article{Hou2023,
author = {Hou, Shanshan and Tian, Zezhong and Zhao, Dan and Liang, Ying and Dai, Suming and Ji, Qiuhua and Fan, Zhiying and Liu, Zhihao and Liu, Meitong and Yang, Yan},
title = {Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation‐Related Biomarkers: A GRADE‐Assessed Systematic Review and Updated Meta‐Analysis of Randomized Controlled Trials},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202200800}
}
EUVIMED